Autolus Therapeutics plc (AUTL) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -65.32M | -67.32M | -67.9M | -72.78M | -75.56M | -37.93M | -76.74M | -51.08M | -40.51M | -24.83M | -40.19M | -38.15M |
| Operating CF Margin % | -249.13% | -277.58% | -320.37% | -347.85% | -841.29% | -130806.9% | - | - | -401.49% | - | -9898.52% | - |
| Operating CF Growth % | 13.56% | -77.47% | 11.52% | -42.48% | -86.52% | -52.76% | -90.95% | -33.91% | 4.49% | -70.49% | -25.97% | -23.82% |
| Net Income | -71.6M | -90.33M | -79.11M | -47.92M | -70.16M | -27.61M | -82.09M | -58.27M | -52.69M | -77.17M | -45.85M | -45.55M |
| Depreciation & Amortization | 2.7M | 4.57M | 595K | 4.31M | 2.28M | 2.08M | 1.94M | 4.18M | 1.81M | 1.77M | 1.38M | 1.51M |
| Stock-Based Compensation | 3.56M | 3.44M | 3.83M | 4.29M | 2.87M | 6.23M | 4.02M | 2.94M | 2.28M | 3.27M | 2.86M | 2.66M |
| Deferred Taxes | -16K | -1.17M | 13K | 384K | 487K | 141K | -168K | 74K | -232K | -466K | -238K | -87K |
| Other Non-Cash Items | 16.51M | 15.11M | -33.85M | -10.93M | 6.66M | -15.79M | -2.44M | 8.91M | 22.07M | 26.92M | 12.38M | 2.65M |
| Working Capital Changes | -16.48M | 1.05M | 40.62M | -22.92M | -17.7M | -2.99M | 2M | -8.92M | -13.75M | 20.83M | -10.72M | 668K |
| Change in Receivables | -3.63M | 8.57M | -6M | -12.39M | -14.34M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -2.54M | 0 | 29.12M | -11.44M | -10.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.17M | -7.52M | 5.42M | 1.53M | 1.86M | 331K | 276K | -335K | 1.32M | -578K | -3.19M | 3.49M |
| Cash from Investing | 96.15M | 86.54M | 35.55M | 95.92M | -59.55M | -383.59M | -9.59M | -841K | -533K | -1.48M | -1.5M | -4.39M |
| Capital Expenditures | 0 | -23.76M | 15.52M | -7.28M | -8.24M | -11.11M | -9.59M | -841K | -533K | -1.48M | -1.5M | -4.39M |
| CapEx % of Revenue | 10.24% | 97.98% | 73.23% | 34.78% | 91.77% | 38317.24% | - | - | 5.28% | - | 368.97% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -2.69M | 24.65M | -28.02M | 0 | 0 | -372.48M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -2.06M | -1.8M | -1.77M | -768K | 0 | 30.01M | 185K | -2.08M | 561.44M | 23K | 4K | -219K |
| Debt Issued (Net) | -2.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 185K | 0 | 549.98M | 0 | 4K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -3.46K | -1.8M | -1.77M | -768K | 0 | 30.01M | 0 | -2.08M | 11.46M | 23K | 0 | -219K |
| Net Change in Cash | 26.78M | 18.01M | -37.71M | 28.08M | -131.55M | -429.73M | -48.42M | -52.59M | 519.21M | -16.51M | -50.98M | -35.52M |
| Free Cash Flow | -68M | -91.09M | -52.38M | -80.06M | -83.81M | -61.79M | -86.33M | -51.92M | -41.05M | -26.31M | -41.69M | -42.54M |
| FCF Margin % | -259.37% | -375.55% | -247.14% | -382.63% | -933.07% | -213068.97% | - | - | -406.77% | - | -10267.49% | - |
| FCF Growth % | 18.86% | -47.41% | 39.33% | -54.18% | -104.18% | -134.85% | -107.09% | -22.07% | 10.85% | -73.1% | -7.71% | -27.17% |
| FCF per Share | -0.26 | -0.34 | -0.20 | -0.30 | -0.31 | -0.23 | -0.32 | -0.20 | -0.18 | -0.15 | -0.24 | -0.24 |
| FCF Conversion (FCF/Net Income) | 0.91x | 0.75x | 0.86x | 1.52x | 1.08x | 1.37x | 0.93x | 0.88x | 0.77x | 0.32x | 0.88x | 0.84x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 1.03M | 9K | 0 | 0 | 984K | 0 | 0 | 0 | 0 |